Feedback / Questions
VE202 - Vedanta Biosci
https://www.businesswire.com/news/home/20250813204990/en/PureTech-Founded-Entity-Vedanta-Biosciences-Announces-Phase-2-Study-of-VE202-in-Ulcerative-Colitis-Did-Not-Meet-Primary-Endpoint
Aug 13, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next